Firmly Commit to R&D
Practice Medical Real-Name System

Intelligently Innovate in Pharmaceuticals
Guard the Dignity of Life

Transcend National Boundaries
Jointly Blueprint for Health

News

The senior management team of Shaanxi Tianrdi Renhe Pharmaceutical Co., Ltd. made a grand appearance at the 89th PharmChina of 2024(WUHAN) to jointly draw a new blueprint for the pharmaceutical industry

Quality as the Foundation for Growth, Pursuing Excellence in Standards Shaanxi Tiandi Renhe Pharmaceutical Co., Ltd. initiated a series of activities for the Quality Month.

Sincere congratulations to Chairman Mr. Yang Cheng on being elected as the new President of the Shaanxi Alumni Association of the University of South China

Shaanxi Tiandi Renhe Pharmaceutical Co., Ltd. Holds Master-Apprentice Ceremony for New Employees

Weinan City Vice mayor open to the factory inspection guidance, group general manager Jia Shutian and plant management leaders participated in the reception

The company signed a strategic cooperation agreement with Wuhan Fuxing Bio-Pharmaceutical Co., LTD

Chemical drug clinical trial approval documents declared by the company

Synthetic Pharmaceutical won the first prize in the biomedical group of the 4th China Innovation and Entrepreneurship Competition

Chairman Yang Cheng's message to the 2023 graduates of his Alma mater, Nanhua University

The first Hua Chuang Synthesis Scholarship was awarded at the University of South China

Founded in

2024

Exclusive Chinese Patent Medicine

5

+varieties

Innovative Drugs (Chemical Drugs / Traditional Chinese Medicines)

6

varieties

Intellectual property rights granted patents

30

types

About Us

Huachuang Synthesis (USA) Co., Ltd. was established on January 7, 2024. It is a wholly-owned subsidiary of Huachuang Synthesis Co., Ltd. and is located at 475 S GRAND CENTRAL PKWY, LAS VEGAS, NV 89106, USA. Huachuang Synthesis Pharmaceutical Co., Ltd. was established through the overall shareholding system restructuring and transformation in 2014 from Shaanxi Synthesis Pharmaceutical Co., Ltd., which was founded in April 2009. In March 2015, it was officially listed on the National Equities Exchange and Quotations (NEEQ, also known as the "New Third Board"), with the stock code: 832077 and a m...